Eledon Pharmaceuticals, Inc. SEC filings ELDN
Eledon Pharmaceuticals, Inc. has 614 filings in SEC EDGAR's recent list, going back to Jun 18, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 11, 2026 | — |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| UPLOAD | Letter from the SEC | May 7, 2026 | — |
| EFFECT | Filing | Oct 2, 2024 | — |
| CORRESP | Letter to the SEC | Sep 30, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2024 | — |
| NT 10-Q | Filing | Aug 14, 2024 | Jun 30, 2024 |
| EFFECT | Filing | Jun 5, 2024 | — |
| CORRESP | Letter to the SEC | Jun 3, 2024 | — |
| UPLOAD | Letter from the SEC | May 30, 2024 | — |
| D | Filing | May 23, 2024 | — |
| EFFECT | Filing | Jun 2, 2023 | — |
| CORRESP | Letter to the SEC | May 31, 2023 | — |
| UPLOAD | Letter from the SEC | May 24, 2023 | — |
| D | Filing | May 22, 2023 | — |
| EFFECT | Filing | May 21, 2021 | — |
| CORRESP | Letter to the SEC | May 18, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2021 | — |
| EFFECT | Filing | Dec 22, 2020 | — |
| CORRESP | Letter to the SEC | Dec 17, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2020 | — |
| CORRESP | Letter to the SEC | Nov 13, 2020 | — |
| PRER14A | Filing | Nov 13, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2020 | — |
| D | Filing | Sep 25, 2020 | — |
| EFFECT | Filing | Apr 3, 2020 | — |
| CORRESP | Letter to the SEC | Apr 2, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2020 | — |
| D | Filing | Jan 27, 2020 | — |
| EFFECT | Filing | Jun 17, 2019 | — |
| CORRESP | Letter to the SEC | Jun 14, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2019 | — |
| D | Filing | May 10, 2019 | — |
| RW | Filing | Sep 7, 2018 | — |
| EFFECT | Filing | Jul 31, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 31, 2018 | — |
| CORRESP | Letter to the SEC | Jul 30, 2018 | — |
| CT ORDER | Filing | Sep 26, 2017 | — |
| EFFECT | Filing | Aug 9, 2017 | — |
| CORRESP | Letter to the SEC | Aug 7, 2017 | — |
| CORRESP | Letter to the SEC | Aug 3, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2017 | — |
| 8-A12B/A | Filing | Jun 23, 2017 | — |
| CT ORDER | Filing | May 4, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2017 | — |
| PRER14A | Amendment no 2 prer14a | Mar 24, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2017 | — |
| PRER14A | Filing | Mar 9, 2017 | — |
| IRANNOTICE | Filing | Mar 3, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 23, 2017 | — |
| CT ORDER | Filing | May 16, 2016 | — |
| IRANNOTICE | Filing | Mar 10, 2016 | — |
| EFFECT | Filing | Oct 23, 2015 | — |
| CORRESP | Letter to the SEC | Oct 21, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 20, 2015 | — |
| CT ORDER | Filing | Jun 11, 2015 | — |
| CT ORDER | Filing | Apr 8, 2015 | — |
| CT ORDER | Filing | Sep 22, 2014 | — |
| EFFECT | Filing | Sep 16, 2014 | — |
| CORRESP | Letter to the SEC | Sep 12, 2014 | — |
| CORRESP | Letter to the SEC | Sep 12, 2014 | — |
| CERTNAS | Auto-generated paper document | Sep 12, 2014 | — |
| 8-A12B | Form 8-a12b | Sep 12, 2014 | — |
| CORRESP | Letter to the SEC | Aug 25, 2014 | — |
| DRS/A | Filing | Jul 16, 2014 | — |
| DRS/A | Filing | Jun 27, 2014 | — |
| UPLOAD | Letter from the SEC | May 30, 2014 | — |
| DRS | Filing | May 2, 2014 | — |
| D | Filing | May 15, 2013 | — |
| D | Filing | Sep 20, 2011 | — |
| D | Filing | May 6, 2009 | — |
| REGDEX | Auto-generated paper document | Oct 27, 2008 | — |
| REGDEX | Auto-generated paper document | Jun 18, 2007 | — |
Showing 74 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELDN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1404281
- Former names
- Eledon Pharmaceuticals, Inc. (until Oct 30, 2026); Novus Therapeutics, Inc. (until Dec 22, 2020); Tokai Pharmaceuticals Inc (until May 4, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.